Trials / Completed
CompletedNCT04718636
A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Participants
A PHASE 1, OPEN-LABEL, RANDOMIZED, 2-WAY CROSSOVER STUDY ON THE EFFECTS OF CC-99677 ON THE PHARMACOKINETICS OF AN ORAL CONTRACEPTIVE IN HEALTHY FEMALE SUBJECTS
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Celgene · Industry
- Sex
- Female
- Age
- 18 Years – 48 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the effect of CC-99677 coadministration on the pharmacokinetics (PK) of an oral contraceptive (OC).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oral Contraceptive (Ortho Tri-Cyclen or its generic equivalent) | Daily |
| DRUG | CC-99677 | Daily |
Timeline
- Start date
- 2020-09-30
- Primary completion
- 2021-08-03
- Completion
- 2021-08-03
- First posted
- 2021-01-22
- Last updated
- 2021-10-28
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04718636. Inclusion in this directory is not an endorsement.